Generics: latest news - GoINPHARMA
Wednesday, 16 January 2019 - 17:25

Generics

Sanofi invests €350m on new vaccine production plant

France-based Sanofi has confirmed this week a significant €350m (CA$500m) investment to build a vaccine production plant in its plant in Toronto, Canada. The new investment makes the Canadian site one of the main plants of the group, with over…

A detailed analysis of the biosimilars market

The Basel-based daily Neue Zürcher Zeitung has published a long article about the biosimilars market and its dynamics. Biotech companies are developing at a rate with few equals and delivered revenues of approximately $100bn in the US in 2017, which…

Hard times and complex dynamics for the generics market

When Teva, the largest generic drugs manufacturer in the world, last Thursday announced poor second-quarter results and a consequent slash of dividends (-75%) and staff (7,000), investors were not extremely surprised, as other generics producers already reported similar trends. Teva,…

Generics industry consolidation ongoing: Novartis targets Amneal

Novartis is reportedly in talks to acquire U.S. generic-drugs maker Amneal Pharmaceuticals in the hope of reviving the subsidiary Sandoz by consolidating the industry. Amneal, founded in 2002, has a workforce of 4,000 and a portfolio including approximately 150 molecules,…